Close Menu

This article has been updated from a previous version to clarify the nature of the partnership between Evosep and Thermo Fisher.

NEW YORK (GenomeWeb) – Thermo Fisher Scientific and Evosep announced on Monday a partnership to develop and promote workflows for clinical proteomics.

The collaboration will be centered out of Thermo Fisher's Boston-based Precision Medicine Science Center and will combine its mass spec systems with Evosep's liquid chromatography to develop robust, high-throughput clinical proteomic methods, the companies said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.